Tahlia Scheinberg

Garvan Institute of Medical Research

Australia

Research Interests

Explore related searches

Professors in Australia Professors in Cancer Biology Cancer Biology professors in Australia

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (14)

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Collaborators (9)

Alison Zhang

Macquarie University

AUSTRALIA

View details

Madeleine Cornelia Strach

Clinical Senior Lecturer

University of Sydney

AUSTRALIA

View details

Andrew Martin

Professor of Biostatistics

University of Sydney

AUSTRALIA

View details

Anthony M. Joshua

University Health Network

CANADA

View details

Andrew Hoy

Associate Professor

University of Sydney

AUSTRALIA

View details

Gillian Heller

Macquarie University

AUSTRALIA

View details

Lisa M. Butler

University of Adelaide

AUSTRALIA

View details

Michael Sullivan

Honorary Professor of Paediatrics

University of Otago Christchurch

NEW ZEALAND

View details

Phillip Stricker

Conjoint Professor

University of New South Wales

AUSTRALIA

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Tahlia Scheinberg

Research Interests

Explore related searches

Contact this professor

Articles (14)

Immunotherapy in metastatic prostate cancer

Association of the circulating lipid panel, PCPro, with clinical outcomes in metastatic hormone-sensitive prostate cancer: post hoc analysis of the ENZAMET phase III randomised trial (ANZUP 1304)

An Australian mainstream genetic testing program: Clinicians views about current and future practices

Evolocumab in metastatic castration-resistant prostate cancer: study protocol for a single-arm, phase II trial, and initial experience with use of a validated lipid biomarker to direct therapy

PCPro: a clinically accessible, circulating lipid biomarker signature for poor-prognosis metastatic prostate cancer

Targeting lipid metabolism in metastatic prostate cancer

Modulation of plasma lipidomic profiles in metastatic castration-resistant prostate cancer by simvastatin

Evaluation of a mainstream genetic testing program for women with ovarian or breast cancer

Evaluation of a mainstream model of genetic testing for men with prostate cancer

Catastrophic chemotherapy toxicity leading to diagnosis of Fanconi anaemia due to FANCD1/BRCA2 during adulthood: description of an emerging phenotype

Overcoming enzalutamide resistance in metastatic prostate cancer by targeting sphingosine kinase

Mainstream consent programs for genetic counseling in cancer patients: A systematic review

PD‐1 blockade using pembrolizumab in adolescent and young adult patients with advanced bone and soft tissue sarcoma

Pharmacodynamics effects of CDK4/6 inhibitor LEE011 (ribociclib) in high-risk, localised prostate cancer: a study protocol for a randomised controlled phase II trial (LEEP study: LEE011 in high-risk, localised Prostate cancer)

Collaborators (9)

Alison Zhang

Madeleine Cornelia Strach

Andrew Martin

Anthony M. Joshua

Andrew Hoy

Gillian Heller

Lisa M. Butler

Michael Sullivan

Phillip Stricker

Make your next move.